Nickel alterations of TLR2-dependent chemokine profiles in lung fibroblasts are mediated by COX-2

American Journal of Respiratory Cell and Molecular Biology

Volumn 38, Issue 5, 2008, Pages 591-599

  Brant, Kelly A ^a   Fabisiak, James P ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chemokines; COX 2; Fibroblasts; Inflammation; Nickel

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NICKEL; NICKEL SULFATE; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 2; CHEMOKINE; CXCL10 PROTEIN, HUMAN; CYCLOOXYGENASE 2 INHIBITOR; IL8 PROTEIN, HUMAN; MACROPHAGE STIMULATORY LIPOPEPTIDE 2; OLIGOPEPTIDE; PTGS2 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MICROBIAL COLONIZATION; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; FIBROBLAST; GENE EXPRESSION PROFILING; GENETICS; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION;

NISO;

CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-8; LUNG; NICKEL; OLIGOPEPTIDES; TOLL-LIKE RECEPTOR 2;

EID: 42949116914     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0314OC     Document Type: Article

References (50)

1. Davidson CI, Phalen RF, Solomon PA. Airborne particulate matter and human health: a review. Aerosol Sci Technol 2005;39:737-749.
2. Schwartz J. What are people dying of on high air pollution days? Environ Res 1994;64:26-35.
3. Sigaud S, Goldsmith CA, Zhou H, Yang Z, Fedulov A, Imrich A, Kobzik L. Air pollution particles diminish bacterial clearance in the primed lungs of mice. Toxicol Appl Pharmacol 2007;223:1-9.
4. Yang HM, Antonini JM, Barger MW, Butterworth L, Roberts BR, Ma JK, Castranova V, Ma JY. Diesel exhaust particles suppress macrophage function and slow the pulmonary clearance of Listeria monocytogenes in rats. Environ Health Perspect 2001;109:515-521.
5. Fabisiak JP, Gao F, Thomson RG, Strieter RM, Watkins SC, Dauber JH. Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2006;291:L781-L793.
6. Iyama K, Zhang S, Lo SC. Effects of mycoplasmal LAMPs on receptor responses to steroid hormones in mammalian cells. Curr Microbiol 2001;43:163-169.
7. Gao F, Barchowsky A, Nemec AA, Fabisiak JP. MIcrobial stimulation by Mycoplasma fermentans synergistically amplifies IL-6 release by human lung fibroblasts in response to residual oil fly ash (ROFA) and nickel. Toxicol Sci 2004;81:467-479.
8. Laden F, Neas LM, Dockery DW, Schwartz J. Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect 2000;108:941-947.
9. Lippmann M, Ito K, Hwang JS, Maciejczyk P, Chen LC. Cardiovascular effects of nickel in ambient air. Environ Health Perspect 2006;114:1662-1669.
10. Cruz MJ, Costa R, Marquilles E, Morell F, Munoz X. [Occupational asthma caused by chromium and nickel.] Arch Bronconeumol 2006;42:302-306. (in Spanish)
11. Oller AR, Costa M, Oberdorster G. Carcinogenicity assessment of selected nickel compounds. Toxicol Appl Pharmacol 1997;143:152-166.
12. Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med 2000;161:1185-1190.
13. Tsoutsou PG, Gourgoulianis KI, Petinaki E, Germenis A, Tsoutsou AG, Mpaka M, Efremidou S, Molyvdas PA. Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis. Respir Med 2006;100:938-945.
14. Cerri C, Chimenti D, Conti I, Neri T, Paggiaro P, Celi A. Monocyte/macrophage-derived microparticles up-regulate inflammatory mediatorsynthesis by human airway epithelial cells. J Immunol 2006;177:1975-1980.
15. Luhrmann A, Deiters U, Skokowa J, Hanke M, Gessner JE, Muhlradt PF, Pabst R, Tschernig T. In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application. Infect Immun 2002;70:3785-3792.
16. Means TK, Golenbock DT, Fenton MJ. Structure and function of Tolllike receptor proteins. Life Sci 2000;68:241-258.
17. Fabisiak JP, Weiss RD, Powell GA, Dauber JH. Enhanced secretion of immune-modulating cytokines by human lung fibroblasts during in vitro infection with Mycoplasma fermentans. Am J Respir Cell Mol Biol 1993;8:358-364.
18. Into T, Dohkan J, Inomata M, Nakashima M, Shibata K, Matsushita K. Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae. Infect Immun 2007;75:2253-2259.
19. Ade N, Antonios D, Kerdine-Romer S, Boisleve F, Rousset F, Pallardy M. NF-{kappa}B plays a major role in the maturation of human dendritic cells induced by NiSO4 but not by DNCB. Toxicol Sci 2007;99:488-501.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
21. Barchowsky A, Soucy NV, O'Hara KA, Hwa J, Noreault TL, Andrew AS. A novel pathway for nickel-induced interleukin-8 expression. J Biol Chem 2002;2002:24225-24231.
22. Rozen S, Skaletsky H. Primer3 on the WWW for general users and biologist programmers, Bioinformatics methods and protocols: methods in molecular biology. Totowa, NJ: HUmana Press; 2000.
23. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987;84:9233-9237.
24. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM. CXC chemokines in angiogenesis. J Leukoc Biol 2000;68:1-8.
25. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 1991;266:19611-19617.
26. Yu Y, Chadee K. Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. J Immunol 1998;161:3746-3752.
27. Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J Clin Invest 1999;104:1001-1006.
28. Emad A, Emad Y. Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res 2007;27:38-43.
29. Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, Leary CP, Polosukhin V, Zhao LH, Sakamoto H, Blackwell TS, et al. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 2004;31:395-404.
30. Keane MP, Arenberg DA, Lynch JPR, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437-1443.
31. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 1992;89:5371-5375.
32. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH. Lung monocyte chemoattractant protein-1 gene expression in bleomycininduced pulmonary fibrosis. J Immunol 1994;153:4733-4741.
33. Inoshima I, Kuwano K, Hamada N, Hagimoto N, Yoshimi M, Maeyama T, Takeshita A, Kitamoto S, Egashira K, Hara N. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2004;286:L1038-L1044.
34. Ding J, Zhang X, Li J, Song L, Ouyang W, Zhang D, Xue C, Costa M, Melendez JA, Huang C. Nickel compounds render anti-apoptotic effect to human bronchial epithelial Beas-2B cells by induction of cyclooxygenase-2 through an IKKbeta/p65-dependent and IKKalpha- and p50-independent pathway. J Biol Chem 2006;281:39022-39032.
35. Cao D, Bromberg PA, Samet JM. COX2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. Am J Respir Cell Mol Biol 2007;37:232-239.
36. Mitsunari M, Yoshida S, Shoji T, Tsukihara S, Iwabe T, Harada T, Terakawa N. Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J Reprod Immunol 2006;72:46-59.
37. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
38. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 1998;273:29279-29282.
39. Mitsunari M, Yoshida S, Shoji T, Tsukihara S, Iwabe T, Harada T, Terakawa N. Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J Reprod Immunol 2006;72:46-59.
40. Vichai V, Suyarnsesthakorn C, Pittayakhajonwut D, Sriklung K, Kirtikara K. Positive feedback regulation of COX-2 expression by prostaglandin metabolites. Inflamm Res 2005;54:163-172.
41. Faour WH, He Y, He QW, de Ladurantaye M, Quintero M, Mancini A, Di Battista JA. Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J Biol Chem 2001;276:31720-31731.
42. Kanda N, Watanabe S. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431. J Invest Dermatol 2002;119:1080-1089.
43. Piper PJ, Vane JR, Wyllie JH. Inactivation of prostaglandins by the lungs. Nature 1970;225:600-604.
44. Takayama K, Garcia-Cardena G, Sukhova GK, Comander J, Gimbrone MA Jr, Libby P. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 2002;277:44147-44154.
45. Caristi S, Piraino G, Cucinotta M, Valenti A, Loddo S, Teti D. Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes. J Biol Chem 2005;280:14433-14442.
46. Moore BB, Ballinger MN, White ES, Green ME, Herrygers AB, Wilke CA, Toews GB, Peters-Golden M. Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2. J Immunol 2005;174:5644-5649.
47. Zelikoff JT, Schermerhorn KR, Fang K, Cohen MD, Schlesinger RB. A role for associated transition metals in the immunotoxicity of inhaled ambient particulate matter. Environ Health Perspect 2002;110:871-875.
48. Deva R, Shankaranarayanan P, Ciccoli R, Nigam S. Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B. J Immunol 2003;171:3047-3055.
49. Rhee SH, Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 2000; 275:34035-34040.
50. Park GY, Christman JW. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol 2006;290:L797-L805.